Atherosclerosis

Oct 5 2025

Occurrence of coronary events in the absence of traditional risk factors: Understanding residual risk

Arnold N, Goßling A, Weimann J, Bay B, Zeller T, Ferrario MM, Palmieri L, Amouyel P, Moitry M, Ferrières J, Brenner H, Tamosiunas A, Malyutina S, Männistö S, Drygas W, Grassi G, Grimsgaard S, Linneberg A, Söderberg S, Iacoviello L, Sans S, Schnabel R, Veronesi G, Thorand B, Tunstall-Pedoe H, Kee F, Salomaa V, Kuulasmaa K, Blankenberg S, Waldeyer C, Ojeda F, Magnussen C, Koenig W; MORGAM investigators.

Atherosclerosis. 2025 Oct; 409:120475. doi: 10.1016/j.atherosclerosis.2025.120475. Epub 2025 Aug 9. PMID: 40829292

https://pubmed.ncbi.nlm.nih.gov/40829292/

Apr 5 2025

Prognostic utility of high-sensitivity troponins according to atherosclerotic vascular disease severity.

Atherosclerosis, Publications

Waldeyer C, Zeller T, Blankenberg S, Bay B.

Atherosclerosis. 2025 Apr;403:119167. doi: 10.1016/j.atherosclerosis.2025.119167. Epub 2025 Mar 20. PMID: 40186960

https://pubmed.ncbi.nlm.nih.gov/40186960/

Nov 1 2020

Association of high-sensitivity troponin T and I with the severity of stable coronary artery disease in patients with chronic kidney disease.

Atherosclerosis, Publications

Brunner FJ, Kröger F, Blaum C, Goßling A, Lorenz T, van Erckelens E, Brätz J, Westermann D, Blankenberg S, Zeller T, Waldeyer C, Seiffert M.

Atherosclerosis. 2020 Nov;313:81-87. doi: 10.1016/j.atherosclerosis.2020.09.024. IF 3,919. PMID: 33032237.

https://pubmed.ncbi.nlm.nih.gov/33032237

Research

Team

Publications

Institute Updates

Occurrence of coronary events in the absence of traditional risk factors: Understanding residual risk

Prognostic utility of high-sensitivity troponins according to atherosclerotic vascular disease severity.

Association of high-sensitivity troponin T and I with the severity of stable coronary artery disease in patients with chronic kidney disease.

Institute for Cardiogenetics

About Us

Information